Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Williams

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Analytical Chemistry|April 8, 2011
Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyesSioned M Griffiths, Neenu Singh, Gareth J S Jenkins, et al.
Biomaterials|May 12, 2009
NanoGenotoxicology: the DNA damaging potential of engineered nanomaterialsNeenu Singh, Bella Manshian, Gareth J S Jenkins, et al.
Biomaterials|October 27, 2011
The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticlesNeenu Singh, Gareth J S Jenkins, Bryant C Nelson, et al.
Nanotoxicology|January 24, 2012
Single-walled carbon nanotubes: differential genotoxic potential associated with physico-chemical propertiesBella B Manshian, Gareth Js Jenkins, Paul M Williams, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2015
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT TrialChih-Jian Lih, David J Sims, Robin D Harrington, et al.
Plos One|July 30, 2015
Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded TissueDanielle Mercatante Carrick, Michele G Mehaffey, Michael C Sachs, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid DisordersCecilia Cs Yeung, Srikrishna K Narava, Ting-Chia Chang, et al.
JAMA Oncology|December 30, 2020
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized TrialKevin Kalinsky, Fangxin Hong, Carolyn K McCourt, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Analytical Chemistry|April 8, 2011
Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyesSioned M Griffiths, Neenu Singh, Gareth J S Jenkins, et al.
Biomaterials|May 12, 2009
NanoGenotoxicology: the DNA damaging potential of engineered nanomaterialsNeenu Singh, Bella Manshian, Gareth J S Jenkins, et al.
Biomaterials|October 27, 2011
The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticlesNeenu Singh, Gareth J S Jenkins, Bryant C Nelson, et al.
Nanotoxicology|January 24, 2012
Single-walled carbon nanotubes: differential genotoxic potential associated with physico-chemical propertiesBella B Manshian, Gareth Js Jenkins, Paul M Williams, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2015
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT TrialChih-Jian Lih, David J Sims, Robin D Harrington, et al.
Plos One|July 30, 2015
Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded TissueDanielle Mercatante Carrick, Michele G Mehaffey, Michael C Sachs, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid DisordersCecilia Cs Yeung, Srikrishna K Narava, Ting-Chia Chang, et al.
JAMA Oncology|December 30, 2020
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized TrialKevin Kalinsky, Fangxin Hong, Carolyn K McCourt, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
Pageof 3